Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Cash from Investing Activities (2016 - 2026)

Cartesian Therapeutics (RNAC) has disclosed Cash from Investing Activities for 12 consecutive years, with -$27000.0 as the latest value for Q1 2026.

  • For Q1 2026, Cash from Investing Activities rose 97.49% year-over-year to -$27000.0; the TTM value through Mar 2026 reached -$4.4 million, up 52.19%, while the annual FY2025 figure was -$5.5 million, 37.61% up from the prior year.
  • Cash from Investing Activities hit -$27000.0 in Q1 2026 for Cartesian Therapeutics, up from -$492000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $28.1 million in Q1 2023 and bottomed at -$29.9 million in Q3 2022.
  • Average Cash from Investing Activities over 5 years is $336500.0, with a median of -$423000.0 recorded in 2024.
  • Year-over-year, Cash from Investing Activities surged 194.65% in 2023 and then crashed 13125.0% in 2024.
  • Cartesian Therapeutics' Cash from Investing Activities stood at $5.5 million in 2022, then grew by 18.36% to $6.5 million in 2023, then plummeted by 105.45% to -$354000.0 in 2024, then plummeted by 38.98% to -$492000.0 in 2025, then surged by 94.51% to -$27000.0 in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$27000.0, -$492000.0, and -$1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.